LUNAC Therapeutics Spun Out to Develop Next Generation Anticoagulants, and Announces Series A Funding Round
November 14, 2019
Novel anticoagulants to minimise bleeding risk by targeting activated Factor XII Builds on a decade of academic research into Factor XII Investment round led by